课题基金 / 基金详情

SEATTLE BREAST CANCER RESERCH PROGRAM

SEATTLE BREAST CANCER RESERCH PROGRAM
西雅图乳腺癌研究计划
批准号:
2545374
负责人:
David B Thomas
金额:
$45.79万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-09-30 至 2000-09-29

项目摘要

项目成果

David B Thomas的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Funds are requested, to develop within the Fred Hutchinson Cancer Research Center a multidisciplinary breast cancer research program, named the Seattle Breast Cancer Research Program. The purpose of the program will be to stimulate innovative multidisciplinary research designed especially to provide a greater understanding of the factors that influence normal mammary epithelial cell growth and regulation, tumor promotion, and progression of existing carcinomas. It is assumed that such knowledge will lead to methods of primary prevention, and to improved methods to identify precancerous and early neoplastic lesions and hence also to better methods of secondary prevention and treatment. These purposes will be achieved by enhancing communication and collaboration among investigators in multiple fields through seminars, retreats, and joint pilot projects, and through the identification of needs for the recruitment of additional investigators from disciplines not adequately represented currently in our cancer center. A unique feature of our center is the strength of existing population-based resources and research. Another major strength is the quality and diversity of existing laboratory-based investigations at the cellular and molecular level in both human and non-human systems. Through the proposed program activities we propose to strengthen existing links and develop new collaborative studies that bridge these two general investigative areas, and focus these efforts on studies of breast cancer. Our ability to conduct studies in multiple defined populations will enhance the validity and applicability of our results to other setting. In addition, access to clinics that serve women with or at high risk of breast cancer will provide opportunities for translational activities to clinical problems. Plans and an institutional commitment to sustain this program on a permanent basis are described.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1055-9965.epi-11-0781
发表时间: 2011-12
期刊: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子: --
作者: [Malone KE, Daling JR, Doody DR, O'Brien C, Resler A, Ostrander EA, Porter PL]
通讯作者: Porter PL
Retinoic acid receptor beta2 inhibition of metastasis in mouse mammary gland xenografts.
视黄酸受体β2抑制小鼠乳腺异种移植物的转移。
DOI: 10.1023/a:1014906529407
发表时间: 2002
期刊: Breast cancer research and treatment
影响因子: 3.8
作者: [Treuting,PiperM, Chen,LucindaI, Buetow,BernardS, Zeng,Weiping, Birkebak,TedA, Seewaldt,VictoriaL, Sommer,KarenM, Emond,Mary, Maggio-Price,Lillian, Swisshelm,Karen]
通讯作者: Swisshelm,Karen
CONTRACEPTIVE USE AND RISK OF CANCER IN SHANGHAI
DIET, CELL PROLIFERATION AND BREAST CANCER IN SHANGHAI
DIET, CELL PROLIFERATION AND BREAST CANCER IN SHANGHAI
SURVEILLANCE EPIDEMIOLOGY & END RESULTS PROGRAM
海外基金